Overview
- 20 inspections across 18 sites are on record.
- 75 Form 483 observations are attributed to this investigator.
- Most recent recorded activity is 2013-09-10.
At a glance
Inspections
20
Sites
18
Observations
75
Career since
Jul 2008
Recent inspections
Most recent inspections in the published record.
| Site | Date | Category | Form 483 |
|---|---|---|---|
| Catalent CTS, LLC | 10 Sep 2013 | Human Drugs | |
| Hospira, Inc. | 24 Oct 2012 | On file | |
| MPP PHARMA LLC | 5 Nov 2010 | View 483 → | |
| KV Pharmaceutical Company | 20 Aug 2010 | ||
| Ther-RX Corporation | 20 Aug 2010 |
Sites inspected
Catalent CTS, LLCKansas City, United States1 insp.
Hospira, Inc.Mcpherson, United States1 insp.
MPP PHARMA LLCKansas City, United States1 insp.
KV Pharmaceutical CompanyBridgeton, United States1 insp.
Ther-RX CorporationChesterfield, United States1 insp.
Co-investigators
Investigators who share inspections with this person.
Sherry G Bous4 shared
Eric M Mueller4 shared
Thuy T Nguyen4 shared
Bill Tackett3 shared
Michele L Obert3 shared
Tara L Breckenridge2 shared
Rochelle B Young2 shared
Patrick L Wisor2 shared
Warren J Lopicka2 shared
Shirley J Berryman1 shared
Full investigator report
Get the verbatim findings behind Matthew R Sleeter's 75 observations
Source 483 PDFs, verbatim observations, and how each site responded, so your team knows what they cite before they arrive.
- New inspections and Form 483s, mapped to the CFR citation
- Warning letter outcomes, and the citation patterns they repeat
- Their co-investigators, so no surprises about who shows up on site